Alane P Barnes Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Alane P Barnes.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Alane P Barnes. Alane P Barnes is Chief Legal Officer in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Senior VP, Chief Legal Officer in BIOCRYST PHARMACEUTICALS INC ($BCRX) and VP, General Counsel & Corp Sec in BIOCRYST PHARMACEUTICALS INC ($BCRX).
Latest Insider Trading Transactions of Alane P Barnes
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 13 2021 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Chief Legal Officer | Option Exercise | M | 4.73 | 35,852 | 169,580 | 0 | |
May 13 2021 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Chief Legal Officer | Option Exercise | M | 4.73 | 35,852 | 169,580 | 0 | |
May 13 2021 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Chief Legal Officer | Option Exercise | M | 5.45 | 68,000 | 370,600 | 0 | |
May 13 2021 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Chief Legal Officer | Option Exercise | M | 5.45 | 68,000 | 370,600 | 0 | |
May 13 2021 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Chief Legal Officer | Option Exercise | M | 1.42 | 33,132 | 47,047 | 0 | |
May 13 2021 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Chief Legal Officer | Option Exercise | M | 1.42 | 33,132 | 47,047 | 0 | |
May 13 2021 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Chief Legal Officer | Option Exercise | M | 4.73 | 1,648 | 7,795 | 35,852 | |
May 13 2021 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Chief Legal Officer | Option Exercise | M | 4.73 | 1,648 | 7,795 | 35,852 | |
May 13 2021 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Chief Legal Officer | Buy | M | 4.73 | 35,852 | 169,580 | 146,127 | 110.3 K to 146.1 K (+32.51 %) |
May 13 2021 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Chief Legal Officer | Buy | M | 4.73 | 35,852 | 169,580 | 146,127 | 110.3 K to 146.1 K (+32.51 %) |
May 13 2021 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Chief Legal Officer | Sell | S | 12.04 | 102,780 | 1,237,471 | 110,275 | 213.1 K to 110.3 K (-48.24 %) |
May 13 2021 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Chief Legal Officer | Sell | S | 12.04 | 102,780 | 1,237,471 | 110,275 | 213.1 K to 110.3 K (-48.24 %) |
May 13 2021 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Chief Legal Officer | Buy | M | 5.45 | 68,000 | 370,600 | 213,055 | 145.1 K to 213.1 K (+46.88 %) |
May 13 2021 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Chief Legal Officer | Buy | M | 5.45 | 68,000 | 370,600 | 213,055 | 145.1 K to 213.1 K (+46.88 %) |
May 13 2021 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Chief Legal Officer | Buy | M | 1.42 | 33,132 | 47,047 | 145,055 | 111.9 K to 145.1 K (+29.60 %) |
May 13 2021 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Chief Legal Officer | Buy | M | 1.42 | 33,132 | 47,047 | 145,055 | 111.9 K to 145.1 K (+29.60 %) |
May 13 2021 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Chief Legal Officer | Buy | M | 4.73 | 1,648 | 7,795 | 111,923 | 110.3 K to 111.9 K (+1.49 %) |
May 13 2021 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Chief Legal Officer | Buy | M | 4.73 | 1,648 | 7,795 | 111,923 | 110.3 K to 111.9 K (+1.49 %) |
Dec 17 2020 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Senior VP, Chief Le ... | Option Exercise | A | 8.31 | 280,000 | 2,326,800 | 280,000 | |
Dec 15 2020 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Senior VP, Chief Le ... | Option Exercise | M | 4.15 | 13,741 | 57,025 | 0 | |
Dec 15 2020 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Senior VP, Chief Le ... | Sell | S | 7.96 | 13,741 | 109,378 | 108,061 | 121.8 K to 108.1 K (-11.28 %) |
Dec 15 2020 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Senior VP, Chief Le ... | Buy | M | 4.15 | 13,741 | 57,025 | 121,802 | 108.1 K to 121.8 K (+12.72 %) |
Dec 08 2020 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Senior VP, Chief Le ... | Option Exercise | M | 4.15 | 13,741 | 57,025 | 13,741 | |
Dec 08 2020 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Senior VP, Chief Le ... | Sell | S | 6.23 | 13,741 | 85,606 | 108,061 | 121.8 K to 108.1 K (-11.28 %) |
Dec 08 2020 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Senior VP, Chief Le ... | Buy | M | 4.15 | 13,741 | 57,025 | 121,802 | 108.1 K to 121.8 K (+12.72 %) |
Dec 07 2020 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Senior VP, Chief Le ... | Option Exercise | A | 5.45 | 17,000 | 92,650 | 17,000 | |
Feb 19 2020 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Senior VP, Chief Le ... | Option Exercise | A | 11.13 | 21,700 | 241,521 | 21,700 | |
Dec 19 2019 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Senior VP, Chief Le ... | Option Exercise | A | 3.23 | 190,000 | 613,700 | 190,000 | |
Nov 18 2019 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Senior VP, Chief Le ... | Buy | P | 1.45 | 20,000 | 29,000 | 102,061 | 82.1 K to 102.1 K (+24.37 %) |
Dec 21 2018 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Senior VP, Chief Le ... | Option Exercise | A | 7.06 | 190,000 | 1,341,400 | 190,000 | |
Dec 04 2018 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Senior VP, Chief Le ... | Option Exercise | M | 1.42 | 25,000 | 35,500 | 25,000 | |
Dec 04 2018 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Senior VP, Chief Le ... | Sell | S | 9.07 | 44,290 | 401,710 | 77,953 | 122.2 K to 78 K (-36.23 %) |
Dec 04 2018 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | Senior VP, Chief Le ... | Buy | M | 1.42 | 25,000 | 35,500 | 122,243 | 97.2 K to 122.2 K (+25.71 %) |
May 17 2018 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | VP, General Counsel ... | Option Exercise | M | 1.42 | 12,500 | 17,750 | 8,132 | |
May 17 2018 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | VP, General Counsel ... | Payment of Exercise | F | 5.91 | 3,004 | 17,754 | 95,264 | 98.3 K to 95.3 K (-3.06 %) |
May 17 2018 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | VP, General Counsel ... | Buy | M | 1.42 | 12,500 | 17,750 | 98,268 | 85.8 K to 98.3 K (+14.57 %) |
Mar 02 2018 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | VP, General Counsel ... | Option Exercise | M | 3.26 | 6,709 | 21,871 | 0 | |
Mar 02 2018 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | VP, General Counsel ... | Buy | M | 3.26 | 6,709 | 21,871 | 85,768 | 79.1 K to 85.8 K (+8.49 %) |
Jan 23 2018 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | VP, General Counsel ... | Payment of Exercise | F | 5.59 | 1,961 | 10,962 | 77,129 | 79.1 K to 77.1 K (-2.48 %) |
Jan 03 2018 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | VP, General Counsel ... | Payment of Exercise | F | 4.91 | 459 | 2,254 | 79,090 | 79.5 K to 79.1 K (-0.58 %) |
Dec 22 2017 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | VP, General Counsel ... | Option Exercise | A | 5.04 | 62,500 | 315,000 | 62,500 | |
Sep 05 2017 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | VP, General Counsel ... | Option Exercise | A | 11.13 | 18,600 | 207,018 | 18,600 | |
Mar 01 2017 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | VP, General Counsel ... | Option Exercise | A | 5.51 | 150,000 | 826,500 | 150,000 | |
Jan 24 2017 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | VP, General Counsel ... | Payment of Exercise | F | 5.95 | 2,599 | 15,464 | 75,497 | 78.1 K to 75.5 K (-3.33 %) |
Jan 03 2017 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | VP, General Counsel ... | Payment of Exercise | F | 6.33 | 1,281 | 8,109 | 78,096 | 79.4 K to 78.1 K (-1.61 %) |
Sep 16 2016 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | VP, General Counsel ... | Sell | S | 4.27 | 8,357 | 35,684 | 79,377 | 87.7 K to 79.4 K (-9.53 %) |
May 25 2016 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | VP, General Counsel ... | Option Exercise | A | 3.22 | 91,004 | 293,033 | 91,004 | |
Mar 03 2016 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | VP, General Counsel ... | Payment of Exercise | F | 2.13 | 687 | 1,463 | 85,416 | 86.1 K to 85.4 K (-0.80 %) |
Feb 01 2016 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | VP, General Counsel ... | Option Exercise | M | 1.42 | 19,368 | 27,503 | 20,632 | |
Feb 01 2016 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | VP, General Counsel ... | Buy | M | 1.42 | 19,368 | 27,503 | 85,057 | 65.7 K to 85.1 K (+29.48 %) |
Jan 22 2016 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | VP, General Counsel ... | Payment of Exercise | F | 7.55 | 2,599 | 19,622 | 65,689 | 68.3 K to 65.7 K (-3.81 %) |
Jan 05 2016 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | VP, General Counsel ... | Payment of Exercise | F | 10.32 | 1,281 | 13,220 | 68,288 | 69.6 K to 68.3 K (-1.84 %) |
Dec 31 2015 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | VP, General Counsel ... | Option Exercise | A | 10.82 | 43,997 | 476,048 | 43,997 | |
Jun 22 2015 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | VP, General Counsel ... | Sell | S | 15.00 | 3,000 | 45,000 | 68,876 | 71.9 K to 68.9 K (-4.17 %) |
Jun 16 2015 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | VP, General Counsel ... | Option Exercise | A | 5.45 | 17,000 | 92,650 | 17,000 | |
Mar 03 2015 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | VP, General Counsel ... | Payment of Exercise | F | 10.20 | 1,120 | 11,424 | 71,876 | 73 K to 71.9 K (-1.53 %) |
Page: 1